131 related articles for article (PubMed ID: 12080650)
1. [Plasma Lp (a) levels and correlation of Lp (a) with fibrinolysis activation in chronic renal failure].
Zhu J; Xiong X; Zhao S; Wang Z; Lou L; Hang Q
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):366-8. PubMed ID: 12080650
[TBL] [Abstract][Full Text] [Related]
2. [Relationship of lipoprotein(a) to fibrinolytic activities in healthy subjects].
Xiong X; Zhao S; Wang Z; Lo L; Huang Q
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):555-7. PubMed ID: 10806767
[TBL] [Abstract][Full Text] [Related]
3. The fibrinolytic system in chronic renal failure.
Lottermoser K; Petras S; Pöge U; Fimmers R; Hertfelder HJ; Schiermeyer B; Vetter H; Düsing R
Eur J Med Res; 2001 Sep; 6(9):372-6. PubMed ID: 11591527
[TBL] [Abstract][Full Text] [Related]
4. Relation of cardiorespiratory fitness to inflammatory markers, fibrinolytic factors, and lipoprotein(a) in patients with type 2 diabetes mellitus.
Jae SY; Heffernan KS; Lee MK; Fernhall B; Park WH
Am J Cardiol; 2008 Sep; 102(6):700-3. PubMed ID: 18773991
[TBL] [Abstract][Full Text] [Related]
5. [Relationship of age, sex, body weight, smoking, blood lipids and fibrinolytic activities in healthy subjects].
Xiong X; Wang Z; Zhao S
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):65-7. PubMed ID: 11938745
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients.
Buduneli N; Buduneli E; Ciotanar S; Atilla G; Lappin D; Kinane D
J Clin Periodontol; 2004 Jul; 31(7):556-61. PubMed ID: 15191592
[TBL] [Abstract][Full Text] [Related]
7. Lp(a) levels: effects of progressive chronic renal failure and dietary manipulation.
Monzani G; Bergesio F; Ciuti R; Ciciani AM; Martinelli F; Rosati A; Salvadori M
J Nephrol; 1997; 10(1):41-5. PubMed ID: 9241624
[TBL] [Abstract][Full Text] [Related]
8. [Tissue plasminogen activator antigen (t-PA Ag) and tissue plasminogen activator inhibitor (PAI-1) in the course of hemodialysis in patients with chronic renal failure].
Piatkowska M; Kotschy M; Nartowicz E; Rajewski W
Pol Merkur Lekarski; 1997 Jan; 2(9):205-7. PubMed ID: 10907030
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant human erythropoietin on fibrinolytic system in children on continuous ambulatory peritoneal dialysis.
Gündüz Z; Kisaarslan FA; Düsünsel R; Poyrazoglu HM; Saraymen R; Per H
Adv Perit Dial; 1999; 15():278-82. PubMed ID: 10682118
[TBL] [Abstract][Full Text] [Related]
10. Influence of lipoprotein (a) levels and isoforms on fibrinolytic activity--study in families with high lipoprotein (a) levels.
Falcó C; Estellés A; Dalmau J; España F; Aznar J
Thromb Haemost; 1998 Apr; 79(4):818-23. PubMed ID: 9580386
[TBL] [Abstract][Full Text] [Related]
11. [Plasma haemostatic and fibrinolytic activities and their relationship to levels of serum lipids and apolipoproteins in endogenous hypertriglyceridemic patients].
Shen T; Bai H; Liu B; Liu Y; Zhang Z; Deng Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):405-8. PubMed ID: 12910674
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause--influence of hormone replacement therapy.
Estellés A; Cano A; Falcó C; España F; Gilabert J; Grancha S; Aznar J
Thromb Haemost; 1999 Jan; 81(1):104-10. PubMed ID: 10348700
[TBL] [Abstract][Full Text] [Related]
13. Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein (a) genetic polymorphism.
Auguet T; Sentí M; Rubiés-Prat J; Pelegrí A; Pedro-Botet J; Nogués X; Romero R
Nephrol Dial Transplant; 1993; 8(10):1099-103. PubMed ID: 8272223
[TBL] [Abstract][Full Text] [Related]
14. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis.
Wankiewicz A; Iwan-Zietek I; Kotschy M; Gwieździński Z
Med Sci Monit; 2002 Mar; 8(3):CR189-92. PubMed ID: 11887034
[TBL] [Abstract][Full Text] [Related]
15. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
16. The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels.
Asselbergs FW; Williams SM; Hebert PR; Coffey CS; Hillege HL; Navis G; Vaughan DE; van Gilst WH; Moore JH
Thromb Haemost; 2006 Oct; 96(4):471-7. PubMed ID: 17003924
[TBL] [Abstract][Full Text] [Related]
17. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
[TBL] [Abstract][Full Text] [Related]
18. Effect of niceritrol on fibrinolysis and lipoprotein (a) levels in patients with coronary artery disease.
Suefuji H; Ogawa H; Yasue H; Imoto N; Sakamoto T; Miyao Y; Kaikita K; Soejima H; Nishiyama K
Coron Artery Dis; 1996 Feb; 7(2):167-72. PubMed ID: 8813450
[TBL] [Abstract][Full Text] [Related]
19. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion.
Speidl WS; Zeiner A; Nikfardjam M; Geppert A; Jordanova N; Niessner A; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
J Am Coll Cardiol; 2005 Jan; 45(1):30-4. PubMed ID: 15629369
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) in chronic renal disease.
Stenvinkel P; Berglund L
Miner Electrolyte Metab; 1996; 22(1-3):16-21. PubMed ID: 8676811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
